Science Explorer Interactive view Map
Company · Santa Monica · United States

Max Biopharma (United States)

maxbiopharma.comROR OpenAlex
Research works
15
▲ 10% vs 2013–17
Citations
163
11.0 per fractional work
Top-10% rate
18.8%
record average 16.5%
Open access
64%
world 28%

Not ranked overall: Max Biopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.13× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.28× its world share, 0 worksImmunology and Micro…Computer Science: 0.74× its world share, 0 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringMaterials Science: 0.55× its world share, 0 worksMaterials ScienceMedicine: 2.57× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 0.38× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.1×. Every wedge is a field page.

Which research topics does Max Biopharma (United States) publish most on?

By volume in 2022–2025: Hedgehog Signaling Pathway Studies, Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects and SARS-CoV-2 and COVID-19 Research.

Hedgehog Signaling Pathw…0Hedgehog Signaling Pathway Studies: 0 fractional worksVirus-based gene therapy…0Virus-based gene therapy research: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksCAR-T cell therapy research: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksCOVID-19 Clinical Resear…0COVID-19 Clinical Research Studies: 0 fractional worksConnective Tissue Growth Factor Research: 0 fractional worksComputational Drug Discovery Methods: 0 fractional works
Molecular BiologyGeneticsInfectious DiseasesOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hedgehog Signaling Pathway Studies Molecular Biology 0 works
  2. 2 Virus-based gene therapy research Genetics 0 works
  3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  7. 7 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  8. 8 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  9. 9 Connective Tissue Growth Factor Research Molecular Biology 0 works
  10. 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.4%not open35.6%

World: 28% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 19% is written across borders.

How has Max Biopharma (United States)'s research output changed?

Output in 2018–2022 was 10% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Santa Monica

All research institutions in Santa Monica

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.